[{"address1": "4200 Marathon Boulevard", "address2": "Suite 200", "city": "Austin", "state": "TX", "zip": "78756", "country": "United States", "phone": "512 215 2630", "website": "https://lumos-pharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of products and therapies for people with rare diseases. Its primary product candidate is LUM-201, an oral growth hormone secretagogue ibutamoren, which is in Phase III clinical trial for the treatment of idiopathic pediatric growth hormone deficiency and other rare endocrine disorders. The company has a clinical collaboration with Massachusetts General Hospital to evaluate oral LUM-201 in nonalcoholic fatty liver disease. Lumos Pharma, Inc. is headquartered in Austin, Texas.", "fullTimeEmployees": 33, "companyOfficers": [{"maxAge": 1, "name": "Mr. Richard J. Hawkins", "age": 74, "title": "Founder, CEO & Chairman", "yearBorn": 1949, "fiscalYear": 2023, "totalPay": 854352, "exercisedValue": 0, "unexercisedValue": 26296}, {"maxAge": 1, "name": "Dr. John C. McKew Ph.D.", "age": 59, "title": "Chief Scientific Officer & President", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 860382, "exercisedValue": 0, "unexercisedValue": 11771}, {"maxAge": 1, "name": "Ms. Lori D. Lawley CPA", "age": 39, "title": "CFO & Principal Accounting Officer", "yearBorn": 1984, "fiscalYear": 2023, "totalPay": 538229, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lisa Wells Miller", "title": "Senior Director of Investor Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bradley J. Powers J.D.", "age": 44, "title": "Chief Compliance Officer & General Counsel", "yearBorn": 1979, "fiscalYear": 2023, "totalPay": 677078, "exercisedValue": 0, "unexercisedValue": 234894}, {"maxAge": 1, "name": "Mr. Aaron  Schuchart B.B.A., CPA, M.B.A.", "age": 57, "title": "Chief Business Officer", "yearBorn": 1966, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Pisit  Pitukcheewanont FAAP, M.D.", "title": "Chief Medical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Alpa  Parikh", "title": "Senior Vice President of CMC & Supply Management", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Eddie L. Varnado M.B.A.", "title": "Corporate Controller", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 1.45, "open": 1.48, "dayLow": 1.46, "dayHigh": 1.525, "regularMarketPreviousClose": 1.45, "regularMarketOpen": 1.48, "regularMarketDayLow": 1.46, "regularMarketDayHigh": 1.525, "beta": 0.295, "forwardPE": -0.7891892, "volume": 9455, "regularMarketVolume": 9455, "averageVolume": 34557, "averageVolume10days": 64790, "averageDailyVolume10Day": 64790, "bid": 1.41, "ask": 1.57, "bidSize": 100, "askSize": 100, "marketCap": 11850076, "fiftyTwoWeekLow": 1.37, "fiftyTwoWeekHigh": 4.55, "priceToSalesTrailing12Months": 7.7705417, "fiftyDayAverage": 2.274, "twoHundredDayAverage": 2.9005, "currency": "USD", "enterpriseValue": -10810928, "floatShares": 5311836, "sharesOutstanding": 8116490, "sharesShort": 294740, "sharesShortPriorMonth": 294630, "sharesShortPreviousMonthDate": 1717113600, "dateShortInterest": 1719532800, "sharesPercentSharesOut": 0.0363, "heldPercentInsiders": 0.34825, "heldPercentInstitutions": 0.26928, "shortRatio": 26.39, "shortPercentOfFloat": 0.0515, "impliedSharesOutstanding": 8116490, "bookValue": 2.151, "priceToBook": 0.6787541, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -37129000, "trailingEps": -4.58, "forwardEps": -1.85, "pegRatio": -0.04, "enterpriseToRevenue": -7.089, "enterpriseToEbitda": 0.274, "52WeekChange": -0.5535168, "SandP52WeekChange": 0.2086575, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "LUMO", "underlyingSymbol": "LUMO", "shortName": "Lumos Pharma, Inc.", "longName": "Lumos Pharma, Inc.", "firstTradeDateEpochUtc": 1321021800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "bcffe56f-50ef-3693-86d2-3838602f9308", "messageBoardId": "finmb_256380672", "gmtOffSetMilliseconds": -14400000, "currentPrice": 1.46, "targetHighPrice": 28.0, "targetLowPrice": 16.0, "targetMeanPrice": 22.5, "targetMedianPrice": 23.0, "recommendationMean": 1.8, "recommendationKey": "buy", "numberOfAnalystOpinions": 4, "totalCash": 23179000, "totalCashPerShare": 2.856, "ebitda": -39404000, "totalDebt": 518000, "quickRatio": 5.292, "currentRatio": 6.24, "totalRevenue": 1525000, "debtToEquity": 2.97, "revenuePerShare": 0.188, "returnOnAssets": -0.53703, "returnOnEquity": -1.06147, "freeCashflow": -22056624, "operatingCashflow": -34792000, "revenueGrowth": -0.761, "grossMargins": 1.0, "operatingMargins": -65.8303, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-07-22"}]